| Date | Acquired company | Acquiring company | Amount | Related |
|---|---|---|---|---|
| 2015-10-28 | Medcore (Sweden) | Karo Bio (Sweden) | MSEK 18 (€ 1.91 million) | diabetes surgery anesthesia |
| 2015-10-21 | Novartis (Switzerland) | Admune Therapeutics (USA - MA) | undisclosed | Cancer - Oncology |
| 2015-10-19 | AqueSys (USA - CA) | Allergan (Ireland) | $300 million upfront payment and regulatory approval and commercialization milestone payments | Ophtalmological diseases Medical devices |
| 2015-10-15 | Biomnis (France) | Eurofins Scientific (Luxembourg) | € 220 million | CRO Diagnostic Analytical services |
| 2015-10-15 | Synergetics (USA) | Valeant Pharmaceuticals (Canada) | $ 166 million (€ 147.7 million) | Ophtalmological diseases Neurosurgery Technology - Services |
| 2015-10-14 | R-Tech Ueno (Japan) | Sucampo Pharmaceuticals (USA - MD) | ¥33 billion ($278 million) | Gastrointestinal diseases Immunological diseases Ophtalmological diseases Cancer - Oncology |
| 2015-10-01 | Kythera Biopharmaceuticals (USA - CA) | Allergan (Ireland) | $2.1 billion | aesthetic medicine |
| 2015-10-01 | Rimsa - Representaciones e Investigaciones Médicas (Mexico) | Teva Pharmaceutical Industries (Israel) | $2.3 billion | |
| 2015-09-25 | Gecko Health Innovations (USA - MA) | Teva Pharmaceutical Industries (Israel) | undisclosed | Technology - Services
|
| 2015-09-24 | BioNovion (The Netherlands) | Aduro Biotech (USA - CA) | € 29 million | Monoclonal antibody Immune checkpoint inhibitor |
| 2015-09-24 | Phoundry Pharmaceuticals (USA - NC) | Intarcia Therapeutics (USA - MA) | undisclosed | Metabolic diseases |
| 2015-09-22 | Kinesis Pharma (The Netherlands) | Venn Life Sciences (Ireland) | €6.5 million | CRO clinical research |
| 2015-09-18 | NovioGendix (The Netherlands) | MDxHealth (Belgium) | $ 8.8 million | Diagnostic Cancer - Oncology |
| 2015-09-16 | Dezima Pharma (The Netherlands) | Amgen (USA - CA) | up to $1.25 billion | Cardiovascular diseases Metabolic diseases |
| 2015-09-14 | PacificGMP (USA - CA) | Abzena (UK) | $8.4 million | Technology - Services Manufacturing Production |
| 2015-09-11 | Amgen\'s biologics bulk manufacturing facility in Boulder (USA - CO) | AstraZeneca (UK) | undisclosed | Manufacturing Production |
| 2015-09-09 | Bioceros (The Netherlands) | Epirus Biopharmaceuticals (USA - MA) | $14.1 million | Biosimilar drugs |
| 2015-09-09 | NeuroFix Therapeutics (USA - PA) | Medgenics (USA - Israel) | $2 million cash, a series of performance-based milestone payments and sales royalties | Rare diseases |
| 2015-09-08 | Stallergenes (France) Greer Laboratories (USA - NC) | Ares Allergy (UK) | Allergic diseases |
|
| 2015-09-01 | Cardiogen Sciences (USA - CA) | Audentes Therapeutics (USA - CA) | undisclosed | Gene therapy Rare diseases Cardiovascular diseases |
